Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean cyanocobalamin and levomefolate calcium and pyridin hydrochloride and riboflavin?
Displaying drugs 14426 - 14450 of 14515 in total

Cidoxepin

Experimental
Matched Salts name: … Cidoxepin hydrochloride …

Eticlopride

Experimental
Matched Salts name: … Eticlopride hydrochloride …

Aminopromazine

Experimental
Vet approved
Matched Salts name: … Aminopromazine hydrochloride …

Ketocaine

Experimental
Matched Salts name: … Ketocaine hydrochloride …

Mocravimod

Investigational
Matched Salts name: … Mocravimod hydrochloride …

Fidarestat

Experimental

2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE

Experimental

BMS-863233

BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
Investigational
Matched Salts name: … BMS-863233 hydrochloride …

PHA-767491

PHA-767491 is a Cdc7/CDK9 inhibitor.
Investigational
Matched Salts name: … PHA-767491 hydrochloride …

5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE

Experimental

RS-39604

RS-39604 is a selective 5-HT4 receptor antagonist.
Investigational
Matched Salts name: … RS-39604 hydrochloride …

1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One

Experimental

(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE

Experimental

Henatinib

Henatinib has been used in trials studying the treatment of Advanced Solid Cancer.
Investigational

SB-269970

SB-269970 is an experimental drug developed by GlaxoSmithKline. In the studies performed with this agent, it has been suggested that SB-269970 acts either as a selective antagonist or inverse agonist of the serotonin receptor 7 (5-HT7).[A31816,A31817]
Investigational
Matched Salts name: … SB-269970 hydrochloride …

1-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea

Experimental

1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE

Experimental

PCO-371

PCO-371 is under investigation in clinical trial NCT02475616 (A Single Ascending Dose Study of PCO371 in Healthy Volunteers).
Investigational

ATX-101

ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment for the reduction of localized fat deposits. This includes treatment of superficial lipomas (benign tumors of soft tissue composed of mature fat cells), fat deposits in the submental region of the face/neck, and localized fat deposits in...
Investigational
Matched Description: … of soft tissue composed of mature fat cells), fat deposits in the submental region of the face/neck, and …

5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide

Experimental

Cannabinol

Cannabinol (CBN) is a physiologically inactive constituent of Cannabis sativa.
Experimental
Investigational
Matched Categories: … Cannabinoids and similars …

4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION

Experimental

4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION

Experimental

Fostroxacitabine bralpamide

Investigational
Matched Salts name: … Fostroxacitabine bralpamide hydrochloride …

ACA 125

An IgG1 murine monoclonal anti-idiotype antibody (Ab2), ACA-125, was developed to bind to anti-CA 125 antibodies. ACA-125 mimics the tumor-associated antigen CA-125, which can be detected in about 80% of ovarian carcinomas. This new concept of oncological immunotherapy consists of an attempt to trigger the immune system of the host...
Investigational
Matched Description: … To create ACA-125, a hybridoma cell was adapted to serum-free medium and antibody was produced in a hollow …
Displaying drugs 14426 - 14450 of 14515 in total